Company Profile

Oligomerix Inc
Profile last edited on: 9/20/2022      CAGE: 4PQQ8      UEI: MHB5HVJVAK87

Business Identifier: Target identification and validation technologies: enhancing drug discovery process for neurodegenerative diseases
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1300 Morris Park Avenue
Bronx, NY 10461
   (212) 568-0365
Location: Single
Congr. District: 14
County: Bronx

Public Profile

An emerging biotechnology company, Oligomerix is focused on developing disease-modifying therapeutics for neurodegenerative diseases characterized by aberrant tau protein ranging from rare tauopathies such as progressive supranuclear palsy and frontotemporal dementia to Alzheimer’s disease. With a focus on oral, small molecule, tau self-association inhibitors, Oligomerix seeks to develop therapies for Alzheimer’s disease and other dementias that are easy to administer and cost effective, and which are expected significantly to add to newly emerging high-cost therapeutic options such as the monoclonal antibody targeted against beta-amyloid that was recently approved by the US FDA. Oligomerix is headquartered at the Westchester Park Center in White Plains, New York and has lab facilities at the Ullmann Research Center for Health Sciences within the Albert Einstein College of Medicine.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Key People / Management

  James G Moe -- CEO and Founder

  Eliot Davidowitz -- Founder and Chief Scientific Officer

  Bob Foerster -- Chief Financial Officer

  Patricia Lopez -- Lab Manager

  Jack Pasini -- Chief Commercial Officer and Director